Hemispherx (HEB) Surges on News Mgmt to Hold Conference Call Updating Influenza Research Initiatives
Tweet Send to a Friend
Shares of the momentous swine flu play, Hemispherx BioPharma (AMEX: HEB), have surged today following reports earlier that the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
